Tal Zvi Zaks
CIK: 0001690927
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TEVA PHARMACEUTICAL INDUSTRIES LTD
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Aug 5, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sale(S)Direct17 shares at avg. $34.87$592.714 - Jun 5, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct14.5K shares- - May 28, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Award(A)DirectRestricted Share Units
7.2K shares- - Jun 6, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Exercise(M)Direct9.6K shares- - Jun 5, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Award(A)DirectRestricted Share Units
14.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 5, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale(S) | 17 | $34.87 | $593 | Direct |
| Jun 5, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 14,492 | - | $0 | Direct |
| May 28, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Award(A) Restricted Share Units | 7,242 | - | - | Direct |
| Jun 6, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise(M) | 9,632 | - | - | Direct |
| Jun 5, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Award(A) Restricted Share Units | 14,492 | - | - | Direct |
1-5 of 5 transactions
About Zaks Tal Zvi
Zaks Tal Zvi (SEC CIK 0001690927) files insider reports with the SEC as Director of TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA).
Signal8 holds 4 ownership filings by Zaks Tal Zvi, all Form 4s, filed between Jun 9, 2025 and Aug 10, 2026. Those filings report 5 transactions, from Jun 5, 2025 to Aug 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Zaks Tal Zvi's filings is in TEL AVIV.
Recent filings by Zaks Tal Zvi
- Aug 5, 2026: Open-market sale of TEVA shares (Form 4, code S).
- Jun 5, 2026: Option exercise of TEVA shares (Form 4, code M).
- May 28, 2026: Grant or award of TEVA derivative securities (Form 4, code A).
- Jun 6, 2025: Option exercise of TEVA shares (Form 4, code M).
- Jun 5, 2025: Grant or award of TEVA derivative securities (Form 4, code A).
Other insiders filing for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
- Bergwerk Dov, Interim Cheif Legal Officer
- Savage Brian, Interim Chief Legal Officer
- MIGNONE ROBERTO, Director
- Weiss Amir, Chief Accounting Officer
- Satchi-Fainaro Ronit, Director
- Lippman Evan, EVP, Business Development